1246776-22-6

(S)-α-Methylbenzyl ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzylamine. It demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI₅₀ value of 6.9 μM.

(S)-α-Methylbenzyl Ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzanamine, and demonstrates potent growth inhibition of glioma.

(S)-α-Methylbenzyl ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzylamine. It demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI50 value of 6.9 μM.[Cayman Chemical]

Store at -20°C

[1] DAIANE S. DOS SANTOS . Antiproliferative activity of synthetic fatty acid amides from renewable resources[J]. Bioorganic & Medicinal Chemistry, 2015, 23 2: Pages 340-347. DOI: 10.1016/j.bmc.2014.11.019